Community acquired pneumonia (CAP) is one of the most common and morbid conditions encountered in clinical practice, which causes serious morbidity worldwide. In CAP, oxidative stress is linked to inflammation, demonstrated by increased production of interleukin (IL)-6 and tumor necrosis factor (TNF)-α, which attract inflammatory cells and increase oxidant production by these cells. Attenuation of oxidative stress via antioxidants would be expected to result in reduced pulmonary damage. Antioxidants have been found to be effective in alleviating lung injury and protecting against damage of other organs.

开始日期2024-01-01

申办/合作机构

Future University in Egypt

IRCT20200429047235N2 / Recruiting临床3期

The effect of astaxanthin supplementation on antioxidant status, inflammation status, disease severity and physical performance in patients with rheumatoid arthritis

开始日期2023-12-22

申办/合作机构

Isfahan University of Medical Sciences

IRCT20231024059828N1 / Suspended临床1/2期IIT

Investigating the effects of Astaxanthin on the recovery of patients with complete spinal cord injury: A clinical trial study

开始日期2023-12-06

申办/合作机构

Shahid Beheshti University of Medical Sciences

100 项与虾青素相关的临床结果

登录后查看更多信息

100 项与虾青素相关的转化医学

登录后查看更多信息

100 项与虾青素相关的专利（医药）

登录后查看更多信息

3,162

项与虾青素相关的文献（医药）

2024-12-01·Applied microbiology and biotechnology

Selecting a preculture strategy for improving biomass and astaxanthin productivity of Chromochloris zofingiensis.

Article

作者: Yuxin Wang ; Jia Wang ; Shufang Yang ; Qingping Liang ; Ziqiang Gu ; Ying Wang ; Haijin Mou ; Han Sun

Chromochloris zofingiensis is a potential source of natural astaxanthin; however, its rapid growth and astaxanthin enrichment cannot be achieved simultaneously. This study established autotrophic, mixotrophic, and heterotrophic preculture patterns to assess their ameliorative effect on the C. zofingiensis heterotrophic growth state. In comparison, mixotrophic preculture (MP) exhibited the best improving effect on heterotrophic biomass concentration of C. zofingiensis (up to 121.5 g L^-1) in a 20 L fermenter, reaching the global leading level. The astaxanthin productivity achieved 111 mg L^-1 day^-1, 7.4-fold higher than the best record. The transcriptome and ¹³C tracer-based metabolic flux analysis were used for mechanism inquiry. The results revealed that MP promoted carotenoid and lipid synthesis, and supported synthesis preference of low unsaturated fatty acids represented by C18:1 and C16:0. The MP group maintained the best astaxanthin productivity via mastering the balance between increasing glucose metabolism and inhibition of carotenoid synthesis. The MP strategy optimized the physiological state of C. zofingiensis and realized its heterotrophic high-density growth for an excellent astaxanthin yield on a pilot scale. This strategy exhibits great application potential in the microalgae-related industry. KEY POINTS: • Preculture strategies changed carbon flux and gene expression in C. zofingiensis • C. zofingiensis realized a high-density culture with MP and fed-batch culture (FBC) • Astaxanthin productivity achieved 0.111 g L^-1 day^-1 with MP and FBC.

2024-02-16·Bioresource technology

Is the carotenoid production from Phaffia rhodozyma yeast genuinely sustainable? a comprehensive analysis of biocompatibility, environmental assessment, and techno-economic constraints.

Article

作者: Cassamo U Mussagy ; Ana C R V Dias ; Valeria C Santos-Ebinuma ; M Shaaban Sadek ; Mushtaq Ahmad ; Cleverton R de Andrade ; Felipe F Haddad ; Jean L Dos Santos ; Cauê B Scarim ; Jorge F B Pereira ; Juliana Ferreira Floriano ; Rondinelli D Herculano ; Ahmad Mustafa

Microorganisms, such as yeasts, filamentous fungi, bacteria, and microalgae, have gained significant attention due to their potential in producing commercially valuable natural carotenoids. In recent years, Phaffia rhodozyma yeasts have emerged as intriguing non-conventional sources of carotenoids, particularly astaxanthin and β-carotene. However, the shift from academic exploration to effective industrial implementation has been challenging to achieve. This study aims to bridge this gap by assessing various scenarios for carotenoid production and recovery. It explores the use of ionic liquids (ILs) and bio-based solvents (ethanol) to ensure safe extraction. The evaluation includes a comprehensive analysis involving Life Cycle Assessment (LCA), biocompatibility assessment, and Techno-Economic Analysis (TEA) of two integrated technologies that utilize choline-based ILs and ethanol (EtOH) for astaxanthin (+β-carotene) recovery from P. rhodozyma cells. This work evaluates the potential sustainability of integrating these alternative solvents within a yeast-based bioeconomy.

2024-02-16·Small (Weinheim an der Bergstrasse, Germany)

Reversible Temperature Sensing using Blue-Winged Grasshopper Coloracris azureus Wings.

Article

作者: Limin Wang ; Bodo D Wilts

Thermochromic materials have been widely investigated due to their relevance in technological applications, including anti-counterfeiting materials, fashion accessories, displays, and temperature sensors. While many organisms exhibit color changes, few studies have explored the potential of the responsive natural materials for temperature sensing, especially given the often limited and irreversible nature of these changes in live specimens. Here, it is shown that the hindwings of the blue-winged grasshopper Coloracris azureus can act as a reversible, power-free bio-thermometer, transitioning from blue to purple/red in a 30-100°C temperature range. Using microspectrophotometry, light microscopy and Raman microscopy, it is found that the blue color of the wings originates from pigmentary coloration, based on a complex of astaxanthin and proteins. The thermochromic shift from blue to red, induced by a temperature increase, is attributed to a denaturation of this carotenoprotein complex, upon which astaxanthin is released. This process is reversible upon a subsequent temperature decrease. The color changes are both swift and consistent upon temperature change, making the grasshopper's wings suitable as direct visual sensors on thermally dynamic, curved surfaces. The potential possibilities of sustainable, power-free temperature sensors or microthermometers based on biomaterials are demonstrated.

项与虾青素相关的新闻（医药）

2024-03-27

·PRNewswire

Vitamin Shot Market to Reach US$ 988.4 Million by 2034 Amid Growing Awareness of Maintaining Nutrient Levels for Health

Vitamin shots are getting a shot in the arm. FMI predicts a booming market in India, China, and the US, driven by vitamin deficiencies and the growing desire for radiant skin. The report goes beyond the trend to analyze what's fueling this growth, including potential roadblocks and exciting opportunities. It even equips you with investment insights and strategic decision-making tools to capitalize on this flourishing market. NEWARK, Del., March 27, 2024 /PRNewswire/ -- According to Future Market Insights (FMI), the vitamin shot market is set to be valued at US$ 619.8 million in 2024 and reach US$ 988.4 million by 2034. The market is anticipated to surge at a CAGR of 4.8% in the forecast period from 2024 to 2034. Download the Sample PDF report to explore key market insights and trends: The vitamin shot industry is experiencing growth due to several influencing factors. There is a surging awareness of the importance of maintaining optimal nutrient levels for health and well-being. Several people recognize that their diets may not always provide sufficient amounts of essential vitamins and minerals. This leads them to seek out alternative methods of supplementation. Busy lifestyles and high levels of stress have become commonplace in modern society, often resulting in poor dietary habits and nutrient deficiencies. As a result, individuals are turning to vitamin shots as a convenient and efficient way to quickly replenish their nutrient levels and support their health. The rise of wellness culture and the increasing popularity of holistic health practices have contributed to the growing demand for vitamin shots. People are increasingly seeking out natural and alternative remedies to support their health, and vitamin injections align with this trend. Scope of the Vitamin Shot Market Report Key Takeaways from the Report: The global vitamin shot market increased at a CAGR of 4.3% during the historical period from 2019 to 2023. The United States will likely surge at a CAGR of 4.0% in the forecast period. India is estimated to witness a CAGR of around 4.5% from 2024 to 2034. Germany is anticipated to exhibit a CAGR of 4.3% through 2034. Japan will likely grow at a CAGR of 4.4% in the estimated period. "Increasing demand for on-the-go options to obtain daily doses of vitamins quickly without the need for pills is set to create new opportunities in the market. Key companies are focusing on making new shots with clean-label, natural ingredients to cater to the high demand for zero-preservative products," says Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.). Competitive Landscape Leading companies in the global vitamin shot market are focusing on launching new products to cater to the high demand from their consumer base. They are investing in research & development activities to discover innovative products and broaden their existing product lines. For instance, In February 2024, Cadila Pharmaceuticals launched Aqueous Vitamin D Injection to cure the deficiency of vitamin D. An injectable shot of vitamin C was introduced in June 2022 by BEE & YOU, a company that specializes in natural bee products. The product is made with organic certified bee products. Key Players: AdvaCare Pharma Pfizer Vitana X Vitalounge House of Bratz Reviv Sriya Zeon biotech SKG Caring health SwisscheM Empower Pharmacy Kexing Pharma American Regent Purchase now and gain full access to the Vitamin Shot Industry report, featuring comprehensive Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives. Get More Valuable Insights Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the global vitamin shot market, presenting historical demand data (2019 to 2023) and forecast statistics for the period from 2024 to 2034. The global vitamin shot market is segmented by type (vitamin A injection, vitamin B injection, vitamin C injection, vitamin D injection, and vitamin blend injection), application (injectable vitamin shots and oral vitamin shots), nature (synthetic and natural), and region. About the Food & Beverage Division at Future Market Insights (FMI) Expert analysis, actionable insights, and strategic recommendations – the Food & Beverage team at Future Market Insights (FMI) helps clients from all over the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analyzed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help. About the Author: Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.) has 7+ years of management consulting experience. She advises industry leaders and explores off-the-eye opportunities and challenges. She puts processes and operating models in place to support their business objectives. She has exceptional analytical skills and often brings thought leadership to the table. Nandini has vast functional expertise in key niches, including but not limited to food ingredients, nutrition & health solutions, animal nutrition, and marine nutrients. She is also well-versed in the pharmaceuticals, biotechnology, retail, and chemical sectors, where she advises market participants to develop methodologies and strategies that deliver results. Another feather to her cap manifests in the form of process automation. She is vocal about bringing automation to the fore to bring a 360-degrees-round revolution in manufacturing sector. Her core expertise lies in corporate growth strategy, sales and marketing effectiveness, acquisitions and post-merger integration and cost reduction. Nandini has an MBA in Finance from MIT School of Business. She also holds a Bachelor's Degree in Electrical Engineering from Nagpur University, India. Nandini has authored several publications, and quoted in journals including Beverage Industry, Bloomberg, and Wine Industry Advisor. Explore FMI's Extensive Coverage in the Food and Beverage Domain: Prenatal Vitamin Supplement Market Analysis by Confectionery Products and Pharmaceutical Products from 2024 to 2034. – Review and Request to Access the Sample Report. Natural Source Vitamin E Market by Type, Application & Region | Forecast 2022 to 2032. - Review and Request to Access the Sample Report. Vitamin C Ingredients Market by Natural and Synthetic Sources, 2023-2033. - Review and Request to Access the Sample Report. Vitamin D Ingredients Market by Vitamin D2 and Vitamin D3 Ingredients, Forecast, 2023-2033. - Review and Request to Access the Sample Report. Astaxanthin Market Analysis Based on Tablets, Soft Gel Capsules, Powder, and Liquid from 2024 to 2034. - Review and Request to Access the Sample Report. About Future Market Insights (FMI) Future Market Insights (FMI) is a leading market intelligence and consulting service provider, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, the U.S., and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact Us Nandini Singh Sawlani Future Market Insights Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, USA T: +1-845-579-5705 For Sales Enquiries: [email protected] Website: LinkedIn | Twitter | Blogs | YouTube Logo: SOURCE Future Market Insights

2024-03-13

·PRNewswire

KAS Announces $3M Funding Round to Expand Production of its Natural Algae Astaxanthin

Company's innovative approach enables high-quality natural algae astaxanthin production at faster and more affordable rates New funding will support company plans to reach commercialization this year HONOLULU, March 13, 2024 /PRNewswire/ -- Kuehnle AgroSystems ("KAS"), a leading microalgal innovation and production company, today announced that it has raised a $3 million Series A2 funding round led by S2G Ventures. The funding will accelerate the commercialization of KAS's pioneering method for producing natural astaxanthin from microalgae, a key component in sustainable aquaculture systems as well as a clinically proven human nutraceutical. KAS has patented an innovative process that uses dark fermentation in closed vertical tank systems to produce high-quality natural algae astaxanthin. Utilizing a more sustainable feedstock and production method than current natural and synthetic astaxanthin production methods, KAS's process results in lower production costs, higher yields, faster growth times, and less water and energy consumption. Astaxanthin is a carotenoid with antioxidant properties present in natural aquatic algae, which is consumed by salmonids and shrimp and gives these species their characteristic red color. In aquaculture systems, which produce over 50% of the seafood we eat globally, astaxanthin is incorporated to provide similar pigments. However, 95% of astaxanthin currently used in aquaculture feed is synthetic and derived from petrochemicals. KAS aims to replace synthetic with natural algal astaxanthin, addressing a market that is estimated to be valued at around $3.7 billion. "Strong consumer preference for natural inputs is expected to accelerate the transition from synthetic to natural astaxanthin," said Claude Kaplan, chief executive officer of KAS. "With our ability to generate greater astaxanthin output volumes, quicker and at a reduced cost compared to light-dependent methods, this funding strongly positions KAS to respond to the rapidly expanding needs of the market." "KAS's fermentation breakthrough, natural strain development process, and sustainable production method all have the potential to transform the natural astaxanthin market, a key input for more sustainable aquaculture practices that can drive better outcomes for people and the planet," said Larsen Mettler, Managing Director at S2G Ventures. "We are proud to be part of KAS's journey and look forward to supporting the impact they are poised to make in the market." Existing backers of KAS include Aqua-Spark, Hatch and Cavallo Ventures. "We continue to be impressed by the KAS team's capacity to leverage their scientific and commercial knowledge to produce a truly innovative solution for replacing synthetic with natural astaxanthin," said Lissy Smit, CEO at Aqua-Spark. "As the aquaculture industry continues to grow at a rapid pace, we need more companies like KAS that are solving core challenges in the value chain to ensure our food system is healthier and more sustainable for consumers and the planet." KAS will initially launch with its European-based production partner with the capacity to distribute globally. This new funding will enable KAS to exploit its ability to use standard fermentation equipment, to swiftly expand production through leveraging contract manufacturers, with the option to bring production in-house in the future. And while KAS' process is inherently more resource efficient than competitors, the company's technology also holds future potential for recycling the gas generated during fermentation to produce feedstock to be fed back into the fermentation process creating fully circular algal products. About KAS: Kuehnle AgroSystems, Inc. (KAS), founded in 2007, is a Hawaii-based microalgae development company with a world-class team of professionals. KAS uses its extensive library of Hawaiian microalgal strains to research, develop and produce specialty chemicals and raw materials to make life better. Our customers include multinational corporations along with valued regional companies and brands that require sustainable plant-based ingredients for animal feeds, human health, food, and personal care. Industrial fermentation allows our ingredients to be cultured at lower cost with highest efficiency and quality, and enables rapid access to markets by ourselves and our partners. Learn more at kuehnleagro.com. About S2G Ventures: S2G Ventures partners with entrepreneurs who are working on solutions to some of the world's greatest challenges across the food, agriculture, oceans, and energy markets. The firm provides capital, mentorship, and value-added resources to companies pursuing innovative market-based solutions that generate positive social, environmental, and financial returns. S2G structures flexible capital solutions that can range from seed and venture funding through growth equity to debt and infrastructure financing. For more information about S2G, visit s2gventures.com or connect with us on LinkedIn. Media Contact: Chelsea Hokenson [email protected] SOURCE Kuehnle AgroSystems

2024-03-10

·佰傲谷BioValley

揭秘美丽革命 | 合成生物学探索未来护肤

01前言作为生物学领域的一门新兴交叉学科，合成生物学打开了非生命物质向生命物质转化的大门。其工程化设计理念，在遵循生物合成基本规律的基础上，能够对生物体进行有目标的设计、改造乃至重新合成，进而实现新功能或者合成新物质。这种对天然生物体“从无到有”的改造，将生物科技领域基础研究转化为实际社会生产力的关键科学技术，合成生物学也因此成为现代科学最富前景的领域之一。02合成生物学在化妆品领域的现状与挑战合成生物学在新型化妆品领域有着广泛的应用前景：提高原料稀缺性：传统化妆品原料受季节、气候和地域等因素限制。合成生物学可以通过利用微生物或植物细胞工厂合成目标化合物，提高化妆品原料的供给稳定性和可持续性。创新产品开发：通过利用基因编辑、代谢工程等技术，可以合成具有新颖功能和性质的化妆品成分，如抗衰老成分、抗氧化剂、保湿剂等，推动化妆品行业的创新和发展。降低生产成本：不需要大量的植物提取和化学合成，实现对化妆品原料的高效生产，降低生产成本，并且采用环境友好的生产方式，减少对自然资源的依赖和环境污染。可持续发展：通过利用微生物或植物等生物体进行生产，减少对有限资源的依赖，实现资源的可再生利用，促进化妆品行业向更加环保和可持续的方向发展。定制化产品需求：对化妆品原料的定制化生产，根据市场需求和消费者偏好合成具有特定功能和性质的化妆品成分，满足不同消费者的需求。目前，合成生物学在新型化妆品领域的应用尚处于初期阶段。合成生物学技术仍需要不断发展和完善，优化生产工艺和提高产量，以满足化妆品行业对原料的需求。其次，化妆品原料的安全性和稳定性是一个重要考量因素，需要对合成生物学技术合成的化合物进行充分的安全性评估和稳定性测试。除此之外，传统化妆品行业的成熟和保守也是合成生物学在新型化妆品领域应用的一大挑战，需要克服传统观念和行业壁垒，推动合成生物学技术在化妆品行业的广泛应用。 03合成生物学在化妆品领域的应用——生物素材合成用于生产新型化妆品原料在化妆品领域，原料的选择对产品的质量、功效和市场竞争力都具有重要影响。原料是化妆品的基础，直接影响产品的成分配比、质地和性能。利用合成生物学构建的“人造微生物工厂”，可用于医学临床、美容护肤和保健食品等产品所需功能性原料的生产。同时，用合成生物学生产化妆品原料不仅具有节约资源、收率高、生产成本低、周期短、保护环境和符合可持续发展理念等优势，也顺应了当下纯净美妆的潮流趋势。1、角鲨烷角鲨烷是少有的化学稳定性高，使用感极佳的动物油脂。因其良好的亲肤性、渗透性，以及辅助修复敏感肌的能力，在护肤品中有广泛应用。然而传统角鲨烷由蓝鲸和鲨鱼的肝脏中的角鲨烯氢化制得，难以大量获取。利用合成生物学，将酿酒酵母改造成生产角鲨烯的高效的细胞工厂，为角鲨烷的大量合成提供了途径，既烯降低了角鲨烷的生产成本，也让这种优良的成分得以用于化妆品中。2、虾青素虾青素是一种酮式类胡萝卜素，广泛存在于水生动物如虾、蟹、鱼和鸟类的羽毛中。虾青素具有极强的抗氧化能力，可以清除二氧化氮、硫化物、二硫化物等，也可降低脂质过氧化作用，有效的抑制自由基引起的脂质过氧化作用，应用十分广泛。但是自然界中虾青素含量远不能满足各大行业需求，因此主要通过人工生产虾青素。酵母菌的生物合成是人工生产虾青素的一个重要方式，利用酵母菌将葡萄糖合成β-胡萝卜素，β-胡萝卜素通过氧化及羟基化生成虾青素。产虾青素的酵母具有很强的代谢能力，可以利用多种底物进行代谢和生物转化，例如单糖、二糖和多糖、有机酸和醇类物质。它还可以迅速利用简单氮源以及复杂混合物甚至工业废料，可有效降低生产成本。3、麦角硫因麦角硫因是一种稀有的天然抗氧化剂，在人体内具有细胞保护作用，是重要的生物活性物质。在化妆品中，麦角硫因具有多种生理功能，包括清除自由基、美白、抗衰老、抗辐射、维持DNA合成和细胞生长等。然而，自然界中麦角硫因很少见，化学合成麦角硫因复杂且昂贵，而生物合成方法降低了成本并提高了产量，为获取麦角硫因提供了更可行的途径。生物合成麦角硫因的途径之一就是利用重组微生物生产。有研究对改造酿酒酵母的代谢路径进，希望重组改造后的酵母能够以葡萄糖为唯一碳源生产麦角硫因，从而降低工业生产麦角硫因的成本。该研究还发现，培养基优化表明添加泛酸盐进一步提高了菌株的生产力，不需要添加氨基酸前体。最终工程菌株生产麦角硫因的效率显著提高，该研究为麦角硫氨酸的低成本发酵生产奠定了基础。4、透明质酸透明质酸大量存在于人体及其它生物组织中，具有极强的保湿性能，在化妆品中主要作为保湿剂，增稠剂，乳化剂使用。透明质酸易在皮肤上形成水化膜提升皮肤润滑感，可促进皮肤对活性物质的吸收，膜的形成在一定程度了有隔离细菌作用，利于皮肤消炎及修护，延缓皮肤老化。生产透明质酸最常用的两种方法是动物组织提取法和微生物发酵法。传统的组织提取法提取过程复杂，生产率较低，受到原料来源限制。而发酵法因成本低、产率高，易规模化生产等优势成为工业生产透明质酸的主流方法。随着制备方法的不断完善，人们对透明质酸的生产需求更注重高质量，目前的研究主要通过基因工程、诱变育种等方式生产特定分子量的透明质酸以满足需要。目前的研究热点之一便是建立一种高效安全的透明质酸制备方法以生产符合各种应用场景的特定分子量透明质酸。5、重组胶原蛋白胶原蛋白是一种结构性蛋白质，在人体中起着重要的支撑和连接作用。它是皮肤、骨骼、肌肉、血管、牙齿等组织的主要成分之一。胶原蛋白占人体总蛋白含量30%以上，其中Ⅰ、Ⅱ、Ⅲ型胶原蛋白占胶原蛋白总量90%以上。在皮肤中，胶原蛋白可以保持皮肤的弹性和紧致度，有助于预防皱纹和松弛。此外，胶原蛋白还有助于促进伤口愈合、增强骨骼和关节的稳定性，对维持身体的整体结构和功能至关重要。胶原蛋白的组织修复功能在化妆品抗衰、修护等方面有良好的应用前景，因此胶原蛋白也成为了近些年化妆品领域的新兴原料。传统胶原蛋白从动物结缔组织中提取获得，提取方法主要有三种：包括高压辅助的物理方法、溶剂抽提的化学方法、酶的生物化学法。但是从动物组织中提取的胶原蛋白，存在动物源疾病等风险。重组胶原蛋白是通过基因工程技术合成的胶原蛋白，其制备过程包括将人工合成的胶原基因导入到宿主细胞中，使其表达和分泌胶原蛋白。重组胶原蛋白组分单一、安全性高而且生产过程可控，并且重组胶原蛋白在组成和结构上与天然胶原蛋白相似，具有良好的生物相容性和生物活性，可以被人体直接吸收并参与构建胶原，帮助进行组织修复和部位填充，其修护皮肤和抗衰等功效在化妆品中的应用有很好的前景。世界范围内，中国是全球率先实现重组胶原蛋白量产的国家，在行业内具有领先地位。04新型化妆品-未来展望与研究方向新型化妆品的未来展望呈现多个方面的发展趋势。未来新型化妆品会趋向天然有机成分，以满足消费者对健康和环保的需求，推动行业向更可持续的方向发展。其次，个性化定制化妆品将成为主流，基于个人基因和肤质数据的定制化妆品将更准确地满足消费者需求。另外，生物合成技术的进步将为化妆品提供更多新型成分选择，从而创造出更安全、更有效的产品。除此之外，数字化技术的应用将极大改变消费者的购物体验，通过虚拟现实和增强现实技术，消费者可以在线体验化妆品效果，提升购物体验和品牌互动性。最后，可持续发展将成为化妆品行业的重要方向，从原料选择到生产和包装的环保方面都将得到改善。因此，新型化妆品的研究方向将聚焦于开发更安全、更有效的成分，提升产品的个性化定制能力，加强数字化技术与消费者体验的结合，以及促进行业的可持续发展。声明文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担, 关于对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。本公众号发布的各类文章重在分享，如有侵权请联系我们，我们将会处理。▲4月12-13日，南京扬子江国际会议中心▲合成生物学为底层技术的绿色生物制造可制备美妆、护肤、医美领域的生物活性原料。利用生物质的原料，微生物细胞或者酶在生物反应器当中，将此原料转化生产出化妆品的原料或产品。这些原料通常包括油性的、粉状的、水性的，表面活性剂、添加剂等，可用于护肤、毛发、彩妆，并且含有美白保湿、抗衰、控油、清洁润肤、修复等功效。2024第二届合成生物学产业博览会（以下简称SBC2024）将于4月12-13日在南京扬子江国际会议中心召开。大会现场特设以“新型医美与化妆品应用专场”，届时将汇聚业界专家聚焦合成生物学颠覆性技术，为医美与化妆品行业的发展带来更多创新可能，提升产品功效。1场主论坛，10场分论坛，80+演讲嘉宾，3000+行业观众，100+行业代表展商，X+特色活动，开启合成生物学技术盛会。最美人间四月天，金陵繁花春意浓，SBC2024诚邀各界同仁南京与会~4月12日下午Topic：重组胶原蛋白的生物制造及应用范代娣西北大学院长&教授Topic：合成生物学如何从研发走向生产黄永康梅特勒托利多细分市场话题待定张浩千蓝晶微生物联合创始人&CEO话题待定合碳创物 Topic：四面体框架核酸TDN与皮肤抗衰老李海航创健医疗首席技术官Topic：抗衰新宠-麦角硫因张巍麦角硫因 CEOTopic：合成生物技术设计和开发高活性、高稳定性透皮纤连蛋白崔俊锋柏垠生物 CEO&联合创始人更多论坛信息向下滑动查看[ 上下滑动，查看内容]扫码添加<佰傲谷小编>微信，即可进入佰傲谷BioValley"合成生物"领域专属群扫码进群，虚位以待跟随谷莉，一起探秘合成生物学的奇迹。点击原文，了解关于4月12日合成生物学产业博览会更多资讯~

100 项与虾青素相关的药物交易

登录后查看更多信息

外链

KEGG	Wiki	ATC	Drug Bank
-	-	V06D	DB06543

研发状态

适应症	最高研发状态	国家/地区	公司
营养紊乱	批准上市	-	Cyanotech Corp. 更多
黄斑变性	无进展	美国更多	-
运动诱发哮喘	无进展	美国更多	-
心血管疾病	无进展	美国更多	-

登录后查看更多信息

临床结果

适应症

分期

评价

查看全部结果

研究	分期	人群特征	评价人数	分组	结果	评价	发布日期


ARVO2011	N/A	-	-	Astaxanthin 1 mg/ml	(壓鹽遞夢糧築鬱積夢顧) = 網鹹鏇憲醖鏇夢範餘鬱製鬱鏇膚積簾鑰網齋鬱 (壓窪廠製夢夢製網鑰觸 ) 更多	-	2011-04-01
				Astaxanthin 0.1 mg/ml	(壓鹽遞夢糧築鬱積夢顧) = 醖餘範艱餘鑰鬱獵遞廠製鬱鏇膚積簾鑰網齋鬱 (壓窪廠製夢夢製網鑰觸 ) 更多
P235 (AAO2001)	N/A	高眼压症 \| 青光眼	-	Nutritional supplement (containing ginko biloba, garlic, and astaxanthin)	(膚願餘觸憲繭築鏇鹹選) = 獵鬱簾衊糧築蓋遞鏇夢獵夢獵壓襯艱膚鑰夢範 (鬱窪憲積夢觸簾選網襯 )	不佳	2001-11-13
				Placebo	(膚願餘觸憲繭築鏇鹹選) = 鹽遞積壓餘壓網網壓糧獵夢獵壓襯艱膚鑰夢範 (鬱窪憲積夢觸簾選網襯 )
ARVO2004	N/A	年龄相关性黄斑变性	50	astaxanthin	(憲鏇遞遞蓋艱襯艱鹹餘) = 選築廠顧鹽鹹積鏇鬱築蓋顧蓋鑰衊遞艱願築窪 (築鑰遞顧築窪簾齋範餘 )	-	2004-05-01
ARVO2011	N/A	-	-	Lutein	構鬱願築膚範醖蓋選繭(蓋淵夢範蓋鏇獵夢鏇鑰) = 鬱淵鑰獵蓋鹽鏇艱醖齋襯餘觸觸觸顧製淵願簾 (築獵淵範選廠鑰範鏇範 )	-	2011-04-01
				(3R, 3’R)-zeaxanthin	構鬱願築膚範醖蓋選繭(蓋淵夢範蓋鏇獵夢鏇鑰) = 鏇醖襯鏇廠鑰鬱憲鏇鹹襯餘觸觸觸顧製淵願簾 (築獵淵範選廠鑰範鏇範 )
ARVO2023	N/A	年龄相关性黄斑变性 A2E	-	Astaxanthin	(範膚淵網構窪願築鬱積) = 艱觸願觸鑰繭齋選構夢衊鬱衊選積廠選願鹹襯 (憲簾壓繭鹽窪積積構築 )	积极	2023-04-23